Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD.

@article{Singh2011ComparisonOA,
  title={Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD.},
  author={Harshabad Singh and Lillian L Werner and Salma Asali and Daniel J. Deangelo and Karen Kuhn Ballen and Philip C. Amrein and Martha Wadleigh and Ilene Galinsky and Brian Wolpin and Joseph A Pidala and Donna S Neuberg and Edward Alan Fox and Richard M Stone and Eyal C. Attar},
  journal={American journal of hematology},
  year={2011},
  volume={86 7},
  pages={625-7}
}
Aichberger and colleagues recently described an association between nilotinib therapy for chronic myelogenous leukemia (CML) and adverse vascular events, which occurred in eight ( 33%) of their 24 CML patients treated with nilotinib: severe peripheral artery disease (PAD; n 5 3), less severe PAD (n 5 1), sudden death (n 5 1), myocardial infarction (n 5 1), spinal infarction (n 5 1), and subdural hematoma (n 5 1) [1]. We were intrigued by these observations because of similar events that… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 70 references

Cytoreduction with clofarabine/Ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute leukaemia

  • S KJBuchholz, E Dammann, G Beutel, M Stadler
  • EBMT Congress, Abstract 948,
  • 2009
Highly Influential
20 Excerpts

Similar Papers

Loading similar papers…